The Use of Next-Generation Sequencing in Treating Non-Squamous Non-Small-Cell Lung Cancer

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Drs. Goeffrey Oxnard and Lauren Ritterhouse consider how next-generation sequencing (NGS) informs treatment of lung cancer patients in providing information on tumor mutational burden, microsatellite instability, unique targetable genomic signatures, as well as novel targets that may be best addressed in a clinical trial.

Related Videos

October 16, 2015

Hot Topics in Treating Cutaneous Malignancies

Dr. Sanjiv Agarwala identifies the newest developments in treatments for melanoma, cutaneous T-cell lymphoma, Merkel cell carcinoma, squamous-cell carcinoma, and invasive-cell carcinoma.

September 7, 2018

The Future of Genomics and Targeted Therapies

Dr Andrey Antov muses on the evolution of genomics and how it could potentially impact targeted therapies and cancer care.